Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Codexis, Inc. (CDXS)
USD2.16
+0.03 (+1.17%)
US NASDAQ Healthcare Biotechnology
Address
200 Penobscot Drive 94063
Redwood City, CA, US
Redwood City, CA, US
CEO
Alison Moore
Website
codexis.com
IPO
2010-04-22
CIK 1200375 ISIN US1920051067
Also trades on
London Stock Exchange · 0I0X.L (USD)
NASDAQ Global Select · CDXS (USD)
Description
Codexis, Inc. is a biotechnology firm dedicated to the discovery, development, and commercialization of enzymes and other protein-based solutions. Its diverse portfolio encompasses advanced biocatalyst products and related services, specialized chemical intermediates vital for subsequent processing steps, and proprietary biocatalyst panels and kits that empower clients to conduct effective chemistry screening. The company also extends its expertise through biocatalyst screening and sophisticated protein engineering services. Central to its operations is the proprietary CodeEvolver protein engineering technology platform. This innovative platform is instrumental in crafting and delivering high-performance biocatalysts capable of driving chemical transformations, thereby significantly enhancing the efficiency and productivity of manufacturing processes. Beyond industrial applications, the CodeEvolver platform is also leveraged for identifying novel biotherapeutic drug candidates for targeted human diseases, as well as for developing enzymes essential for molecular biology research and in vitro diagnostic applications. Primarily serving pharmaceutical manufacturers, Codexis distributes its products through its dedicated direct sales and business development teams across the United States and Europe. Established in 2002, the company maintains its headquarters in Redwood City, California.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD2.16
+0.03 (+1.17%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
1M
Beta
2.50
Float Shares
72.95M
Free Float %
80.3%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -4.15% | -4.87% | +13.39% | +115.25% | +31.61% | +55.83% | -3.79% | -4.15% | -85.72% | -23.26% | -80.84% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (14 ratings, all time)
Buy
Price Targets & DCF
Current price
2.16
Low
5.00
+132.0%
Consensus
5.00
+132.0%
Median
5.00
+132.0%
High
5.00
+132.0%
Ratings Trend (MoM)
71% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 4 | 0 |
| Hold | 2 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | 1 |
5.00
+132.0%
|
| Last Year | 1 |
5.00
+132.0%
|
| All Time | 2 |
8.00
+271.2%
|
Quality scores
Altman Z-Score
-4.43
Distress
Piotroski F-Score
4 / 9
Average
MOAT Score
1 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%+18.6% ★ Q1'26: +102.1% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%+43.8% ★ Q1'26: +61.6% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-52.3% Q1'26: -87.4% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%-55.6% Q1'26: -52.7% (vs Q1'25)
-
ROIC Biotechnology: -16.1%-85.9% Q1'26: -63.6% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+18.7% Q1'26: +10.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-2.16× Q1'26: -3.13× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2011 actual |
Dec 2012 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 4 Rev. Ana. 3 EPS Ana. |
Dec 2027 4 Rev. Ana. 2 EPS Ana. |
Dec 2028 3 Rev. Ana. 2 EPS Ana. |
Dec 2029 2 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
123.87M
est: 96.32M (+28.6%)
|
88.30M
est: 179.57M (-50.8%)
|
41.80M
est: 41.83M (-0.1%)
|
48.84M
est: 48.07M (+1.6%)
|
50.02M
est: 51.27M (-2.4%)
|
60.59M
est: 61.32M (-1.2%)
|
68.46M
est: 71.24M (-3.9%)
|
69.06M
est: 68.90M (+0.2%)
|
104.75M
est: 103.44M (+1.3%)
|
138.59M
est: 137.14M (+1.1%)
|
70.14M
est: 60.89M (+15.2%)
|
59.35M
est: 65.29M (-9.1%)
|
70.39M
est: 67.28M (+4.6%)
|
74.18M
69.78M – 83.29M
+10.3% YoY
|
88.92M
79.36M – 106.68M
+19.9% YoY
|
120.49M
120.33M – 120.65M
+35.5% YoY
|
143.94M
135.40M – 161.61M
+19.5% YoY
|
176.39M
165.92M – 198.04M
+22.5% YoY
|
| EBITDA |
-4.84M
est: -2.04M (-136.9%)
|
-18.17M
est: -15.00M (-21.1%)
|
-2.36M
est: -19.40M (+87.8%)
|
-4.02M
est: -22.29M (+82.0%)
|
-21.93M
est: -23.78M (+7.8%)
|
-10.15M
est: -12.02M (+15.6%)
|
-7.99M
est: -33.04M (+75.8%)
|
-19.37M
est: -22.76M (+14.9%)
|
-16.75M
est: -16.80M (+0.3%)
|
-26.31M
est: -14.19M (-85.4%)
|
-49.28M
est: -30.02M (-64.2%)
|
-58.52M
est: -32.19M (-81.8%)
|
-33.87M
est: -33.17M (-2.1%)
|
-36.58M
-41.06M – -34.40M
-10.3% YoY
|
-43.84M
-52.60M – -39.13M
-19.9% YoY
|
-59.41M
-59.49M – -59.33M
-35.5% YoY
|
-70.97M
-79.68M – -66.76M
-19.5% YoY
|
-86.97M
-97.64M – -81.80M
-22.5% YoY
|
| EBIT |
-16.31M
est: -10.16M (-60.4%)
|
-30.51M
est: -29.04M (-5.1%)
|
-7.77M
est: -21.39M (+63.7%)
|
-8.56M
est: -24.58M (+65.2%)
|
-22.97M
est: -26.21M (+12.4%)
|
-11.30M
est: -14.06M (+19.7%)
|
-12.55M
est: -36.42M (+65.5%)
|
-23.92M
est: -28.59M (+16.3%)
|
-22.70M
est: -28.74M (+21.0%)
|
-31.71M
est: -28.19M (-12.5%)
|
-54.80M
est: -33.55M (-63.4%)
|
-58.35M
est: -35.97M (-62.2%)
|
-39.11M
est: -37.07M (-5.5%)
|
-40.87M
-45.89M – -38.44M
-10.3% YoY
|
-48.99M
-58.77M – -43.72M
-19.9% YoY
|
-66.38M
-66.47M – -66.29M
-35.5% YoY
|
-79.30M
-89.04M – -74.60M
-19.5% YoY
|
-97.18M
-109.11M – -91.41M
-22.5% YoY
|
| Net Income |
-16.55M
est: -10.76M (-53.8%)
|
-30.86M
est: -29.48M (-4.7%)
|
-7.58M
est: -13.58M (+44.2%)
|
-8.56M
est: -13.21M (+35.2%)
|
-23.00M
est: -25.45M (+9.6%)
|
-10.88M
est: -13.49M (+19.3%)
|
-11.94M
est: -8.26M (-44.5%)
|
-24.01M
est: -28.73M (+16.4%)
|
-21.28M
est: -26.14M (+18.6%)
|
-33.59M
est: -56.74M (+40.8%)
|
-76.24M
est: -99.24M (+23.2%)
|
-65.28M
est: -64.98M (-0.5%)
|
-43.97M
est: -54.89M (+19.9%)
|
-38.11M
-41.76M – -31.77M
+30.6% YoY
|
-27.84M
-42.94M – -9.70M
+27.0% YoY
|
-453.7K
-505.2K – -402.1K
+98.4% YoY
|
13.07M
12.06M – 15.16M
+2,981.3% YoY
|
30.06M
27.74M – 34.86M
+130.0% YoY
|
| SGA |
36.94M
est: 25.30M (+46.0%)
|
31.38M
est: -14.57M (+315.4%)
|
22.32M
est: 25.46M (-12.4%)
|
25.42M
est: 29.26M (-13.1%)
|
29.01M
est: 31.20M (-7.0%)
|
29.29M
est: -1.10M (+2,752.8%)
|
31.50M
est: 43.36M (-27.3%)
|
35.05M
est: 5.28M (+563.3%)
|
49.32M
est: 76.18M (-35.3%)
|
52.17M
est: 91.38M (-42.9%)
|
53.25M
est: 39.02M (+36.5%)
|
55.15M
est: 41.85M (+31.8%)
|
47.07M
est: 43.12M (+9.2%)
|
47.54M
44.72M – 53.38M
+10.3% YoY
|
56.99M
50.86M – 68.37M
+19.9% YoY
|
77.22M
77.12M – 77.33M
+35.5% YoY
|
92.25M
86.78M – 103.58M
+19.5% YoY
|
113.05M
106.34M – 126.92M
+22.5% YoY
|
| EPS |
-0.46
est: -0.24 (-91.7%)
|
-0.84
est: -0.96 (+12.5%)
|
-0.19
est: -0.19 (-2.7%)
|
-0.21
est: -0.18 (-16.7%)
|
-0.50
est: -0.35 (-44.2%)
|
-0.21
est: -0.13 (-68.0%)
|
-0.21
est: -0.11 (-86.7%)
|
-0.40
est: -0.35 (-15.3%)
|
-0.33
est: -0.38 (+14.1%)
|
-0.51
est: -0.55 (+6.8%)
|
-1.12
est: -1.09 (-2.4%)
|
-0.89
est: -0.79 (-12.1%)
|
-0.50
est: -0.64 (+21.9%)
|
-0.42
-0.48 – -0.36
+34.9% YoY
|
-0.30
-0.49 – -0.11
+27.5% YoY
|
-0.01
-0.01 – 0.00
+98.3% YoY
|
0.15
0.14 – 0.17
+3,100.0% YoY
|
0.35
0.32 – 0.40
+130.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-06 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-05 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-04 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-01 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-7.32M
OE per share TTM
-0.09
Owner's Yield
-3.13%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
52.3%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
28
Total invested
19.78M
Insider transactions (90d)
0
Beneficial owners (>5%)
17
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NORGES BANK (THE CENTRAL BANK OF NORWAY) | 237.64M | 6.64% | — | — | 235.37M | 2.26M | OO | NORWAY | 2022-02-09 | ↗ |
| 2 | Casdin Capital, LLC | 8.10M | 9.90% | — | 8.10M | — | 8.10M | IA | Delaware | 2024-09-26 | ↗ |
| 3 | Casdin Partners GP, LLC | 8.10M | 9.90% | — | 8.10M | — | 8.10M | OO | Delaware | 2024-09-26 | ↗ |
| 4 | Casdin Partners Master Fund, L.P. | 8.10M | 9.90% | — | 8.10M | — | 8.10M | PN | Delaware | 2024-09-26 | ↗ |
| 5 | Eli Casdin | 8.10M | 9.90% | — | 8.10M | — | 8.10M | HC, IN | Delaware | 2024-09-26 | ↗ |
| 6 | Baillie Gifford & Co (Scottish partnership) | 7.18M | 11.00% | — | — | — | — | IA | SCOTLAND UK | 2022-01-12 | ↗ |
| 7 | Dan Mack | 6.55M | 12.10% | — | 6.55M | — | — | HC | MA | 2019-02-14 | ↗ |
| 8 | Wilmot B. Harkey | 6.55M | 12.10% | — | 6.55M | — | — | HC | MA | 2019-02-14 | ↗ |
| 9 | Nantahala Capital Management, LLC | 5.30M | 8.30% | — | 5.30M | — | — | IA | MA | 2021-02-16 | ↗ |
| 10 | (1) BlackRock, Inc. | 5.14M | 7.90% | 4.98M | — | 5.14M | — | HC | Delaware | 2022-02-03 | ↗ |
| 11 | Abigail P. Johnson | 4.37M | 6.25% | — | — | 4.37M | — | IN | Delaware | 2024-02-09 | ↗ |
| 12 | FMR LLC | 4.37M | 6.25% | 4.34M | — | 4.37M | — | HC | Delaware | 2024-02-09 | ↗ |
| 13 | John Nicols | 4.13M | 6.13% | 3.67M | 460.4K | 3.67M | 460.4K | IN | — | 2021-02-16 | ↗ |
| 14 | Daniel Mack | 3.46M | 5.30% | — | 3.46M | — | — | HC | MA | 2022-02-10 | ↗ |
| 15 | The Vanguard Group - 23-1945930 | 3.40M | 5.24% | — | 113.2K | 3.24M | 159.9K | IA | Pennsylvania | 2022-02-09 | ↗ |
| 16 | ARK Investment Management LLC | 3.24M | 5.00% | 3.24M | — | 3.24M | — | IA | Delaware, United States | 2022-01-10 | ↗ |
| 17 | Vivo Ventures VII, LLC | 2.62M | 4.90% | 2.62M | — | 2.62M | — | OO | Delaware | 2019-02-14 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
28
-96 vs prev Q
New positions
9
Closed positions
104
Increased
20
Reduced
4
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | POTOMAC CAPITAL MANAGEMENT, INC. | 300.0K +300.0K (+100.0%) | 489.00M +489.0M (+100.0%) | 0.33% +0.332 pp | 0.39% +0.393 pp | USD1.63 +0.0% | 1 qtrs NEW |
| 2 | ABRDN PLC | 7.97M +3.9M (+94.7%) | 12.99M +3.0M (+30.1%) | 8.83% +4.035 pp | 0.02% +0.004 pp | USD2.09 -22.0% | 9 qtrs — |
| 3 | BLACKROCK, INC. | 7.40M +251.8K (+3.5%) | 12.06M -5.4M (-30.8%) | 8.19% -0.172 pp | 0.00% 0.000 pp | USD3.19 -48.9% | 6 qtrs — |
| 4 | OPALEYE MANAGEMENT INC. | 6.79M -6.0M (-46.9%) | 11.07M -20.2M (-64.6%) | 7.52% -7.461 pp | 1.46% -2.954 pp | USD2.91 -44.0% | 48 qtrs — |
| 5 | VANGUARD GROUP INC | 4.94M +271.7K (+5.8%) | 8.05M -3.3M (-29.3%) | 5.48% +0.007 pp | 0.00% 0.000 pp | USD9.04 -82.0% | 63 qtrs — |
| 6 | NANTAHALA CAPITAL MANAGEMENT, LLC | 3.99M -40.5K (-1.0%) | 6.50M -3.3M (-33.9%) | 4.42% -0.299 pp | 0.22% -0.127 pp | USD4.38 -62.8% | 56 qtrs — |
| 7 | TELEMARK ASSET MANAGEMENT, LLC | 3.85M -153.6K (-3.8%) | 6.27M -3.5M (-35.8%) | 4.26% -0.423 pp | 0.63% -0.300 pp | USD5.92 -72.5% | 34 qtrs — |
| 8 | AMERIPRISE FINANCIAL INC | 3.79M +1.0M (+36.8%) | 6.18M -584.2K (-8.6%) | 4.20% +0.955 pp | 0.00% 0.000 pp | USD4.38 -62.8% | 33 qtrs — |
| 9 | MILLENNIUM MANAGEMENT LLC | 3.14M -932.4K (-22.9%) | 5.11M -4.8M (-48.5%) | 3.47% -1.290 pp | 0.00% -0.002 pp | USD2.44 -33.2% | 15 qtrs — |
| 10 | PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 2.57M +1.9M (+304.1%) | 4.19M +2.6M (+170.0%) | 2.85% +2.102 pp | 0.39% +0.226 pp | USD1.95 -16.4% | 9 qtrs — |
| 11 | GEODE CAPITAL MANAGEMENT, LLC | 2.03M +33.6K (+1.7%) | 3.30M -1.6M (-32.1%) | 2.24% -0.089 pp | 0.00% 0.000 pp | USD9.30 -82.5% | 63 qtrs — |
| 12 | STATE STREET CORP | 1.60M +62.8K (+4.1%) | 2.61M -1.1M (-30.5%) | 1.78% -0.028 pp | 0.00% +0.000 pp | USD7.91 -79.4% | 39 qtrs — |
| 13 | JACOBS LEVY EQUITY MANAGEMENT, INC | 1.14M -29.7K (-2.5%) | 1.85M -991.9K (-34.9%) | 1.26% -0.106 pp | 0.01% -0.004 pp | USD4.47 -63.5% | 14 qtrs — |
| 14 | UBS GROUP AG | 809.5K +287.1K (+55.0%) | 1.32M +44.9K (+3.5%) | 0.90% +0.285 pp | 0.00% +0.000 pp | USD2.25 -27.6% | 42 qtrs — |
| 15 | FRANKLIN RESOURCES INC | 740.6K -15.6K (-2.1%) | 1.21M -637.9K (-34.6%) | 0.82% -0.065 pp | 0.00% 0.000 pp | USD2.94 -44.6% | 11 qtrs — |
| 16 | RENAISSANCE TECHNOLOGIES LLC | 737.5K +427.0K (+137.5%) | 1.20M +444.5K (+58.7%) | 0.82% +0.454 pp | 0.00% +0.001 pp | USD2.06 -20.9% | 4 qtrs — |
| 17 | GOLDMAN SACHS GROUP INC | 718.1K -6.1K (-0.8%) | 1.17M -596.7K (-33.8%) | 0.80% -0.053 pp | 0.00% 0.000 pp | USD4.06 -59.9% | 61 qtrs — |
| 18 | PRIVATE ADVISOR GROUP, LLC | 654.6K +93.2K (+16.6%) | 1.07M -302.9K (-22.1%) | 0.73% +0.068 pp | 0.01% -0.002 pp | USD4.92 -66.9% | 18 qtrs — |
| 19 | NORTHERN TRUST CORP | 645.3K +22.0 (+0.0%) | 1.05M -522.6K (-33.2%) | 0.72% -0.041 pp | 0.00% 0.000 pp | USD8.55 -80.9% | 51 qtrs — |
| 20 | FMR LLC | 641.9K +57.6K (+9.8%) | 1.05M -379.5K (-26.6%) | 0.71% +0.027 pp | 0.00% +0.000 pp | USD5.76 -71.7% | 44 qtrs — |
| 21 | D. E. SHAW & CO., INC. | 628.3K +454.5K (+261.5%) | 1.02M +600.0K (+141.5%) | 0.70% +0.493 pp | 0.00% +0.000 pp | USD1.85 -11.9% | 2 qtrs — |
| 22 | ASSENAGON ASSET MANAGEMENT S.A. | 566.5K +332.6K (+142.2%) | 923.5K +352.6K (+61.8%) | 0.63% +0.354 pp | 0.00% +0.001 pp | USD2.34 -30.3% | 26 qtrs — |
| 23 | TUDOR INVESTMENT CORP ET AL | 537.8K +— (+0.0%) | 876.7K -435.6K (-33.2%) | 0.60% -0.034 pp | 0.00% -0.001 pp | USD2.44 -33.2% | 7 qtrs — |
| 24 | PERKINS CAPITAL MANAGEMENT INC | 529.5K +221.8K (+72.1%) | 863.1K +112.3K (+15.0%) | 0.59% +0.226 pp | 0.69% +0.024 pp | USD2.49 -34.5% | 10 qtrs — |
| 25 | POST RESCH TALLON GROUP INC. | 511.7K -48.2K (-8.6%) | 834.1K -532.1K (-38.9%) | 0.57% -0.089 pp | 0.70% -0.504 pp | USD4.14 -60.6% | 5 qtrs — |
| 26 | CITADEL ADVISORS LLC | 499.4K +229.4K (+85.0%) | 814.0K +155.4K (+23.6%) | 0.55% +0.237 pp | 0.00% +0.000 pp | USD2.33 -30.0% | 27 qtrs — |
| 27 | MORGAN STANLEY | 431.1K +234.5K (+119.3%) | 702.8K +223.0K (+46.5%) | 0.48% +0.247 pp | 0.00% +0.000 pp | USD3.33 -51.1% | 51 qtrs — |
| 28 | LAZARD ASSET MANAGEMENT LLC | 428.9K +428.9K (+100.0%) | 699.1K +699.1K (+100.0%) | 0.48% +0.475 pp | 0.00% +0.001 pp | USD1.63 +0.0% | 1 qtrs NEW |
| 29 | DIMENSIONAL FUND ADVISORS LP | 406.0K -197.6K (-32.7%) | 661.6K -811.3K (-55.1%) | 0.45% -0.257 pp | 0.00% 0.000 pp | USD6.04 -73.0% | 26 qtrs — |
| 30 | FEDERATED HERMES, INC. | 347.6K +113.4K (+48.4%) | 566.7K -4.9K (-0.9%) | 0.39% +0.111 pp | 0.00% 0.000 pp | USD2.68 -39.2% | 13 qtrs — |
| 31 | NUVEEN, LLC | 300.9K -619.3K (-67.3%) | 490.4K -1.8M (-78.2%) | 0.33% -0.744 pp | 0.00% -0.001 pp | USD2.52 -35.3% | 4 qtrs — |
| 32 | JANE STREET GROUP, LLC | 299.9K +249.7K (+496.8%) | 488.9K +366.3K (+298.7%) | 0.33% +0.274 pp | 0.00% +0.000 pp | USD1.77 -7.9% | 2 qtrs — |
| 33 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 294.7K +275.9K (+1,468.6%) | 480.3K +434.5K (+947.9%) | 0.33% +0.305 pp | 0.00% +0.000 pp | USD1.74 -6.3% | 27 qtrs — |
| 34 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 274.9K +24.2K (+9.6%) | 448.1K -163.7K (-26.8%) | 0.30% +0.011 pp | 0.00% +0.000 pp | USD9.95 -83.6% | 39 qtrs — |
| 35 | PLATINUM INVESTMENT MANAGEMENT LTD | 264.5K +— (+0.0%) | 431.1K -214.2K (-33.2%) | 0.29% -0.017 pp | 0.10% +0.058 pp | USD3.20 -49.1% | 8 qtrs — |
| 36 | STONEPINE CAPITAL MANAGEMENT, LLC | 256.1K +167.8K (+190.2%) | 417.5K +202.1K (+93.8%) | 0.28% +0.180 pp | 0.30% +0.130 pp | USD1.91 -14.7% | 2 qtrs — |
| 37 | BARCLAYS PLC | 244.9K +37.2K (+17.9%) | 399.1K -240.4K (-37.6%) | 0.27% +0.028 pp | 0.00% 0.000 pp | USD3.28 -50.3% | 38 qtrs — |
| 38 | BANK OF NEW YORK MELLON CORP | 204.7K -3.5K (-1.7%) | 333.7K -174.4K (-34.3%) | 0.23% -0.017 pp | 0.00% +0.000 pp | USD8.77 -81.4% | 63 qtrs — |
| 39 | ATOM INVESTORS LP | 184.7K +184.7K (+100.0%) | 301.0K +301.0K (+100.0%) | 0.20% +0.205 pp | 0.02% +0.024 pp | USD1.63 +0.0% | 1 qtrs NEW |
| 40 | STIFEL FINANCIAL CORP | 177.8K -100.6K (-36.1%) | 289.7K -389.4K (-57.3%) | 0.20% -0.129 pp | 0.00% 0.000 pp | USD2.55 -36.1% | 8 qtrs — |
| 41 | INVESCO LTD. | 174.6K +51.5K (+41.8%) | 284.6K -15.9K (-5.3%) | 0.19% +0.049 pp | 0.00% +0.000 pp | USD3.29 -50.5% | 21 qtrs — |
| 42 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 150.9K +50.0K (+49.6%) | 246.0K -236.0 (-0.1%) | 0.17% +0.049 pp | 0.01% 0.000 pp | USD2.28 -28.5% | 11 qtrs — |
| 43 | WELLS FARGO & COMPANY/MN | 122.0K +45.4K (+59.3%) | 198.9K +12.0K (+6.4%) | 0.14% +0.046 pp | 0.00% +0.000 pp | USD2.56 -36.3% | 57 qtrs — |
| 44 | ALLIANCEBERNSTEIN L.P. | 118.1K +— (+0.0%) | 192.6K -95.7K (-33.2%) | 0.13% -0.008 pp | 0.00% +0.000 pp | USD10.36 -84.3% | 31 qtrs — |
| 45 | ROYAL BANK OF CANADA | 116.6K -293.6K (-71.6%) | 190.0K -811.0K (-81.0%) | 0.13% -0.351 pp | 0.00% 0.000 pp | USD4.16 -60.8% | 37 qtrs — |
| 46 | DIAMETRIC CAPITAL, LP | 112.3K -17.6K (-13.6%) | 183.0K -133.9K (-42.3%) | 0.12% -0.028 pp | 0.05% -0.069 pp | USD2.44 -33.2% | 2 qtrs — |
| 47 | RHUMBLINE ADVISERS | 108.6K -3.2K (-2.9%) | 177.0K -95.8K (-35.1%) | 0.12% -0.011 pp | 0.00% 0.000 pp | USD7.28 -77.6% | 39 qtrs — |
| 48 | MAN GROUP PLC | 108.0K -25.8K (-19.3%) | 176.0K -150.5K (-46.1%) | 0.12% -0.037 pp | 0.00% 0.000 pp | USD2.44 -33.2% | 2 qtrs — |
| 49 | STRS OHIO | 99.1K +— (+0.0%) | 161.5K -80.3K (-33.2%) | 0.11% -0.006 pp | 0.00% 0.000 pp | USD3.64 -55.2% | 20 qtrs — |
| 50 | ACADIAN ASSET MANAGEMENT LLC | 88.4K +28.0K (+46.4%) | 142.0K -4.0K (-2.7%) | 0.10% +0.027 pp | 0.00% +0.000 pp | USD2.58 -36.8% | 15 qtrs — |
| 51 | JAIN GLOBAL LLC | 85.9K +85.9K (+100.0%) | 140.0K +140.0K (+100.0%) | 0.10% +0.095 pp | 0.00% +0.001 pp | USD1.63 +0.0% | 1 qtrs NEW |
| 52 | LPL FINANCIAL LLC | 78.8K -8.8K (-10.1%) | 128.5K -85.4K (-39.9%) | 0.09% -0.015 pp | 0.00% +0.000 pp | USD3.40 -52.1% | 12 qtrs — |
| 53 | XTX TOPCO LTD | 74.6K +57.3K (+330.9%) | 121.5K +79.3K (+187.8%) | 0.08% +0.062 pp | 0.00% +0.001 pp | USD1.82 -10.4% | 3 qtrs — |
| 54 | BANK OF AMERICA CORP /DE/ | 70.0K +20.2K (+40.7%) | 114.1K -7.3K (-6.0%) | 0.08% +0.019 pp | 0.00% +0.000 pp | USD5.59 -70.8% | 52 qtrs — |
| 55 | AQR CAPITAL MANAGEMENT LLC | 64.7K -19.4K (-23.1%) | 105.4K -99.7K (-48.6%) | 0.07% -0.027 pp | 0.00% 0.000 pp | USD3.58 -54.5% | 17 qtrs — |
| 56 | POINT72 ASSET MANAGEMENT, L.P. | 63.1K +63.1K (+100.0%) | 102.8K +102.8K (+100.0%) | 0.07% +0.070 pp | 0.00% +0.000 pp | USD1.63 +0.0% | 1 qtrs NEW |
| 57 | TWO SIGMA ADVISERS, LP | 59.4K +31.9K (+116.0%) | 96.8K +29.7K (+44.3%) | 0.07% +0.034 pp | 0.00% +0.000 pp | USD6.26 -74.0% | 22 qtrs — |
| 58 | RUSSELL INVESTMENTS GROUP, LTD. | 59.1K +10.6K (+21.9%) | 96.3K -21.9K (-18.6%) | 0.07% +0.009 pp | 0.00% +0.000 pp | USD3.82 -57.3% | 17 qtrs — |
| 59 | QUADRATURE CAPITAL LTD | 54.4K +27.5K (+102.2%) | 88.7K +23.2K (+35.3%) | 0.06% +0.029 pp | 0.00% +0.000 pp | USD2.03 -19.7% | 4 qtrs — |
| 60 | DEUTSCHE BANK AG\ | 51.4K +49.8K (+3,021.2%) | 83.8K +79.8K (+1,984.9%) | 0.06% +0.055 pp | 0.00% +0.000 pp | USD1.70 -4.1% | 48 qtrs — |
| 61 | SG AMERICAS SECURITIES, LLC | 50.3K +28.8K (+133.5%) | 82.0K +29.0K (+54.7%) | 0.06% +0.031 pp | 0.00% 0.000 pp | USD1.98 -17.7% | 27 qtrs — |
| 62 | PARADIGM CAPITAL MANAGEMENT INC/NY | 50.0K +— (+0.0%) | 81.5K -40.5K (-33.2%) | 0.06% -0.003 pp | 0.00% -0.002 pp | USD3.01 -45.8% | 12 qtrs — |
| 63 | PRICE T ROWE ASSOCIATES INC /MD/ | 44.3K +— (+0.0%) | 73.0K -36.0K (-33.0%) | 0.05% -0.003 pp | 0.00% +0.000 pp | USD8.43 -80.7% | 17 qtrs — |
| 64 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 41.4K +2.7K (+6.9%) | 67.5K -27.1K (-28.6%) | 0.05% +0.001 pp | 0.00% 0.000 pp | USD3.15 -48.3% | 7 qtrs — |
| 65 | JPMORGAN CHASE & CO | 41.0K +2.6K (+6.9%) | 66.8K -26.7K (-28.6%) | 0.05% +0.001 pp | 0.00% +0.000 pp | USD4.93 -66.9% | 33 qtrs — |
| 66 | PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | 39.8K -6.9K (-14.8%) | 64.9K -49.1K (-43.1%) | 0.04% -0.011 pp | 0.00% 0.000 pp | USD2.23 -26.9% | 10 qtrs — |
| 67 | TWO SIGMA INVESTMENTS, LP | 39.8K +17.1K (+75.0%) | 64.9K +9.4K (+16.9%) | 0.04% +0.018 pp | 0.00% +0.000 pp | USD8.06 -79.8% | 26 qtrs — |
| 68 | COMMONWEALTH EQUITY SERVICES, LLC | 37.3K -4.3K (-10.4%) | 60.9K -41.1K (-40.3%) | 0.04% -0.007 pp | 0.00% 0.000 pp | USD3.79 -57.0% | 8 qtrs — |
| 69 | ADVISOR GROUP HOLDINGS, INC. | 36.6K -500.0 (-1.3%) | 59.6K -31.1K (-34.3%) | 0.04% -0.003 pp | 0.00% +0.000 pp | USD2.50 -34.8% | 24 qtrs — |
| 70 | INTECH INVESTMENT MANAGEMENT LLC | 35.5K -5.5K (-13.5%) | 57.9K -42.3K (-42.2%) | 0.04% -0.009 pp | 0.00% 0.000 pp | USD3.20 -49.1% | 6 qtrs — |
| 71 | PRELUDE CAPITAL MANAGEMENT, LLC | 34.8K -1.1K (-3.2%) | 56.7K -31.0K (-35.3%) | 0.04% -0.004 pp | 0.00% -0.003 pp | USD2.44 -33.2% | 2 qtrs — |
| 72 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 32.8K +3.3K (+11.1%) | 53.4K -18.5K (-25.7%) | 0.04% +0.002 pp | 0.00% +0.000 pp | USD6.20 -73.7% | 51 qtrs — |
| 73 | BLAIR WILLIAM & CO/IL | 30.4K -4.9K (-13.9%) | 49.5K -36.6K (-42.5%) | 0.03% -0.008 pp | 0.00% 0.000 pp | USD9.66 -83.1% | 39 qtrs — |
| 74 | CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 30.4K +30.4K (+100.0%) | 49.5K +49.5K (+100.0%) | 0.03% +0.034 pp | 0.01% +0.012 pp | USD1.63 +0.0% | 1 qtrs NEW |
| 75 | EVERGREEN CAPITAL MANAGEMENT LLC | 29.0K +29.0K (+100.0%) | 47.3K +47.3K (+100.0%) | 0.03% +0.032 pp | 0.00% +0.001 pp | USD1.63 +0.0% | 1 qtrs NEW |
| 76 | KRILOGY FINANCIAL LLC | 30.1K +72.0 (+0.2%) | 46.7K -17.9K (-27.7%) | 0.03% -0.002 pp | 0.00% -0.001 pp | USD2.44 -33.2% | 2 qtrs — |
| 77 | PERSISTENT ASSET PARTNERS LTD | 27.8K +27.8K (+100.0%) | 45.3K +45.3K (+100.0%) | 0.03% +0.031 pp | 0.02% +0.020 pp | USD1.63 +0.0% | 1 qtrs NEW |
| 78 | TOWER RESEARCH CAPITAL LLC (TRC) | 27.4K +17.4K (+174.8%) | 44.7K +20.3K (+83.6%) | 0.03% +0.019 pp | 0.00% +0.000 pp | USD2.02 -19.3% | 23 qtrs — |
| 79 | GUGGENHEIM CAPITAL LLC | 27.4K +27.4K (+100.0%) | 44.6K +44.6K (+100.0%) | 0.03% +0.030 pp | 0.00% +0.000 pp | USD1.63 +0.0% | 1 qtrs NEW |
| 80 | ELMWOOD WEALTH MANAGEMENT, INC. | 21.7K +— (+0.0%) | 35.4K -17.6K (-33.2%) | 0.02% -0.001 pp | 0.01% -0.008 pp | USD2.44 -33.2% | 3 qtrs — |
| 81 | BNP PARIBAS ARBITRAGE, SNC | 20.7K +4.1K (+24.4%) | 33.7K -6.8K (-16.9%) | 0.02% +0.004 pp | 0.00% +0.000 pp | USD2.86 -43.0% | 39 qtrs — |
| 82 | PROSHARE ADVISORS LLC | 20.2K +3.0K (+17.4%) | 32.9K -9.1K (-21.6%) | 0.02% +0.002 pp | 0.00% +0.000 pp | USD3.59 -54.6% | 21 qtrs — |
| 83 | POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY | 19.4K +— (+0.0%) | 31.7K -15.7K (-33.2%) | 0.02% -0.001 pp | 0.00% 0.000 pp | USD4.77 -65.8% | 5 qtrs — |
| 84 | AIGEN INVESTMENT MANAGEMENT, LP | 17.6K +1.8K (+11.4%) | 28.7K -9.9K (-25.6%) | 0.02% +0.001 pp | 0.01% +0.001 pp | USD2.36 -30.9% | 2 qtrs — |
| 85 | ENVESTNET ASSET MANAGEMENT INC | 17.1K -50.6K (-74.8%) | 27.9K -137.4K (-83.1%) | 0.02% -0.060 pp | 0.00% +0.000 pp | USD4.34 -62.4% | 27 qtrs — |
| 86 | NEW YORK STATE COMMON RETIREMENT FUND | 16.9K +— (+0.0%) | 27.5K -13.7K (-33.2%) | 0.02% -0.001 pp | 0.00% +0.000 pp | USD12.25 -86.7% | 39 qtrs — |
| 87 | STATE OF WYOMING | 16.9K +3.8K (+28.8%) | 27.5K -4.5K (-14.0%) | 0.02% +0.003 pp | 0.00% -0.001 pp | USD2.26 -27.9% | 3 qtrs — |
| 88 | NAVALIGN, LLC | 15.3K +15.3K (+100.0%) | 25.0K +25.0K (+100.0%) | 0.02% +0.017 pp | 0.01% +0.006 pp | USD1.63 +0.0% | 1 qtrs NEW |
| 89 | VOYA INVESTMENT MANAGEMENT LLC | 14.8K +— (+0.0%) | 24.2K -12.0K (-33.2%) | 0.02% -0.001 pp | 0.00% +0.000 pp | USD9.29 -82.5% | 35 qtrs — |
| 90 | CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 14.7K -1.1K (-7.0%) | 24.0K -14.6K (-37.9%) | 0.02% -0.002 pp | 0.00% -0.001 pp | USD4.77 -65.8% | 5 qtrs — |
| 91 | FIDUCIARY TRUST CO | 13.6K +— (+0.0%) | 22.2K -11.0K (-33.2%) | 0.02% -0.001 pp | 0.00% 0.000 pp | USD4.77 -65.8% | 5 qtrs — |
| 92 | SEI INVESTMENTS CO | 10.5K +— (+0.0%) | 17.2K -8.5K (-33.2%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD3.08 -47.1% | 9 qtrs — |
| 93 | VICTORY CAPITAL MANAGEMENT INC | 10.1K +9.0 (+0.1%) | 16.4K -8.1K (-33.1%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD2.44 -33.2% | 2 qtrs — |
| 94 | GAMCO INVESTORS, INC. ET AL | 10.0K +10.0K (+100.0%) | 16.3K +16.3K (+100.0%) | 0.01% +0.011 pp | 0.00% +0.000 pp | USD1.63 +0.0% | 1 qtrs NEW |
| 95 | LEGAL & GENERAL GROUP PLC | 8.5K +— (+0.0%) | 13.9K -6.9K (-33.2%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD6.51 -75.0% | 39 qtrs — |
| 96 | AMERITAS INVESTMENT PARTNERS, INC. | 8.4K +— (+0.0%) | 13.7K -6.8K (-33.2%) | 0.01% -0.001 pp | 0.00% 0.000 pp | USD6.85 -76.2% | 36 qtrs — |
| 97 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 5.5K -449.0 (-7.6%) | 8.9K -5.5K (-38.2%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD8.10 -79.9% | 39 qtrs — |
| 98 | CITIGROUP INC | 5.4K -50.6K (-90.3%) | 8.8K -127.9K (-93.5%) | 0.01% -0.060 pp | 0.00% 0.000 pp | USD3.10 -47.4% | 39 qtrs — |
| 99 | MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 4.4K +899.0 (+25.8%) | 7.2K -1.4K (-16.0%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD3.72 -56.2% | 5 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 55 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | ROBO Global Healthcare Technology and Innovation ETF HTEC | 0.61% | 302.7K | 0.68% |
| 2 | Invesco NASDAQ Future Gen 200 ETF QQQS | 0.44% | 96.2K | 0.20% |
| 3 | iShares Micro-Cap ETF IWC | 0.05% | 706.7K | 0.60% |
| 4 | iShares Nasdaq US Biotechnology UCITS ETF BTEC.L | 0.02% | 174.4K | 0.35% |
| 5 | iShares Nasdaq US Biotechnology UCITS ETF BTEE.L | 0.02% | 11.7K | 0.35% |
| 6 | iShares Biotechnology ETF IBB | 0.02% | 1.47M | 0.44% |
| 7 | Invesco NASDAQ Biotech UCITS ETF SBIO.L | 0.02% | 70.5K | 0.40% |
| 8 | Invesco Nasdaq Biotechnology ETF IBBQ | 0.02% | 11.3K | 0.19% |
| 9 | iShares Russell 2000 Growth ETF IWO | 0.01% | 1.70M | 0.24% |
| 10 | Vanguard Russell 2000 Growth ETF VTWG | 0.01% | 190.6K | 0.06% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.60
Neutral
Ratio by volume
3.00
Bullish
Buys
3
Sells
5
Shares acquired
1.63M
Shares disposed
20.7K
Cash buys
—
Cash sales
5.00
Net activity
+1,604,509
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-24 | Lutz Stefan | Officer | S-Sale | D | Common Stock | 5,862 | 1.13 | 6.6K | 130,421 | D | ↗ |
| 2026-02-23 | MOORE ALISON | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 993,000 | 1.07 | 1.06M | 993,000 | D | ↗ |
| 2026-02-23 | Lutz Stefan | Officer | A-Award | A | Stock Option (Right to Buy) | 316,100 | 1.07 | 338.2K | 316,100 | D | ↗ |
| 2026-02-23 | Erbez Georgia | Officer | A-Award | A | Stock Option (Right to Buy) | 316,100 | 1.07 | 338.2K | 316,100 | D | ↗ |
| 2026-02-06 | MOORE ALISON | Director / Officer | S-Sale | D | Common Stock | 3,826 | 1.31 | 5.0K | 250,506 | D | ↗ |
| 2026-02-06 | Lutz Stefan | Officer | S-Sale | D | Common Stock | 2,492 | 1.31 | 3.3K | 136,283 | D | ↗ |
| 2026-02-06 | Erbez Georgia | Officer | S-Sale | D | Common Stock | 3,826 | 1.31 | 5.0K | 66,810 | D | ↗ |
| 2026-01-07 | Lutz Stefan | Officer | S-Sale | D | Common Stock | 4,685 | 1.70 | 7.9K | 138,775 | D | ↗ |
| 2025-12-01 | Opaleye Management Inc. | 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 8,533 | 1.67 | 14.2K | 179,989 | I | ↗ |
| 2025-11-28 | Opaleye Management Inc. | 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 105,000 | 1.75 | 183.8K | 10,200,000 | I | ↗ |
| 2025-11-26 | Opaleye Management Inc. | 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 5,000 | 1.74 | 8.7K | 191,012 | I | ↗ |
| 2025-11-21 | WOLF DENNIS P | Director | S-Sale | D | Common Stock | 8,952 | 1.56 | 14.0K | 138,951 | D | ↗ |
| 2025-11-13 | MOORE ALISON | Officer | A-Award | A | Stock Option (Right to Buy) | 500,000 | 1.63 | 815.0K | 500,000 | D | ↗ |
| 2025-11-12 | Opaleye Management Inc. | 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 27,459 | 1.94 | 53.2K | 196,012 | I | ↗ |
| 2025-11-11 | Opaleye Management Inc. | 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 13,211 | 1.80 | 23.8K | 223,461 | I | ↗ |
| 2025-11-11 | De Vre Raymond | Director | S-Sale | D | Common Stock | 1,413 | 1.74 | 2.5K | 87,416 | D | ↗ |
| 2025-11-11 | DILLY STEPHEN GEORGE | Director | A-Award | A | Common Stock | 50,000 | 1.85 | 92.4K | 727,053 | D | ↗ |
| 2025-11-10 | Opaleye Management Inc. | 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 3,318 | 1.73 | 5.8K | 236,682 | I | ↗ |
| 2025-11-07 | Opaleye Management Inc. | 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 10,000 | 1.70 | 17.0K | 240,000 | I | ↗ |
| 2025-11-07 | Lutz Stefan | Officer | — | — | Stock Option (Right to Buy) | 8,800 | 11.79 | 103.8K | 0 | D | ↗ |
| 2025-10-13 | MOORE ALISON | Officer | S-Sale | D | Common Stock | 6,239 | 2.51 | 15.6K | 169,332 | D | ↗ |
| 2025-10-13 | Erbez Georgia | Officer | S-Sale | D | Common Stock | 6,239 | 2.51 | 15.6K | 70,636 | D | ↗ |
| 2025-08-04 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 780 | 2.84 | 2.2K | 12,545,000 | I | ↗ |
| 2025-07-31 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 84,220 | 2.68 | 225.7K | 12,544,220 | I | ↗ |
| 2025-07-30 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 1,578 | 2.80 | 4.4K | 12,460,000 | I | ↗ |
| 2025-07-29 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 8,422 | 2.82 | 23.8K | 12,458,422 | I | ↗ |
| 2025-07-18 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 100,000 | 2.82 | 282.0K | 12,450,000 | I | ↗ |
| 2025-06-27 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 100,000 | 2.39 | 239.0K | 12,350,000 | I | ↗ |
| 2025-06-16 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 50,898 | 2.24 | 114.0K | 12,250,000 | I | ↗ |
| 2025-06-13 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 99,102 | 2.23 | 221.0K | 12,199,102 | I | ↗ |
| 2025-06-12 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 100,000 | 2.25 | 225.0K | 12,100,000 | I | ↗ |
| 2025-06-10 | WOLF DENNIS P | Director | A-Award | A | Common Stock | 40,983 | 0.00 | — | 147,903 | D | ↗ |
| 2025-06-10 | Smith David V | Director | A-Award | A | Common Stock | 40,983 | 0.00 | — | 105,705 | D | ↗ |
| 2025-06-10 | Singhvi Rahul | Director | A-Award | A | Common Stock | 40,983 | 0.00 | — | 137,052 | D | ↗ |
| 2025-06-10 | Richards Christos | Director | A-Award | A | Common Stock | 40,983 | 0.00 | — | 85,133 | D | ↗ |
| 2025-06-10 | PARKER H STEWART | Director | A-Award | A | Common Stock | 40,983 | 0.00 | — | 143,583 | D | ↗ |
| 2025-06-10 | Martinborough Esther | Director | A-Award | A | Common Stock | 40,983 | 0.00 | — | 129,036 | D | ↗ |
| 2025-06-10 | De Vre Raymond | Director | A-Award | A | Common Stock | 40,983 | 0.00 | — | 88,829 | D | ↗ |
| 2025-06-10 | Collins Cynthia | Director | A-Award | A | Common Stock | 40,983 | 0.00 | — | 112,157 | D | ↗ |
| 2025-05-28 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 5,000 | 2.36 | 11.8K | 12,000,000 | I | ↗ |
| 2025-05-23 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 2,320,000 | 2.36 | 5.48M | 11,995,000 | I | ↗ |
| 2025-05-01 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 20,000 | 2.32 | 46.4K | 9,675,000 | I | ↗ |
| 2025-04-30 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 25,000 | 2.31 | 57.7K | 9,655,000 | I | ↗ |
| 2025-04-25 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 25,000 | 2.24 | 55.9K | 9,630,000 | I | ↗ |
| 2025-04-17 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 45,000 | 2.09 | 94.2K | 9,605,000 | I | ↗ |
| 2025-04-16 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 70,000 | 2.13 | 148.9K | 9,560,000 | I | ↗ |
| 2025-04-15 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 25,000 | 2.23 | 55.7K | 9,490,000 | I | ↗ |
| 2025-04-08 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 100,000 | 1.98 | 198.4K | 9,465,000 | I | ↗ |
| 2025-04-03 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 75,000 | 2.30 | 172.7K | 9,365,000 | I | ↗ |
| 2025-04-02 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 5,000 | 2.46 | 12.3K | 9,290,000 | I | ↗ |
| 2025-04-01 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 35,000 | 2.48 | 86.8K | 9,285,000 | I | ↗ |
| 2025-03-28 | Collins Cynthia | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-03-21 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 92,923 | 2.54 | 236.3K | 9,250,000 | I | ↗ |
| 2025-03-20 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 7 | 2.54 | 17.97 | 9,157,077 | I | ↗ |
| 2025-03-13 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 85,000 | 2.54 | 216.2K | 9,150,000 | I | ↗ |
| 2025-03-06 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 100,000 | 2.61 | 261.4K | 9,065,000 | I | ↗ |
| 2025-03-05 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 10,000 | 2.69 | 26.9K | 8,965,000 | I | ↗ |
| 2025-03-04 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 55,000 | 2.64 | 145.4K | 8,955,000 | I | ↗ |
| 2025-03-03 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 47,351 | 2.81 | 133.2K | 8,900,000 | I | ↗ |
| 2025-02-28 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 147,649 | 2.99 | 441.2K | 8,852,649 | I | ↗ |
| 2025-02-12 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 15,000 | 4.00 | 59.9K | 8,705,000 | I | ↗ |
| 2025-02-11 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 12,500 | 4.11 | 51.4K | 8,690,000 | I | ↗ |
| 2025-02-10 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 22,500 | 4.18 | 94.1K | 8,677,500 | I | ↗ |
| 2025-02-05 | Norrett Kevin | Officer | A-Award | A | Stock Option (Right to Buy) | 161,250 | 4.37 | 704.7K | 161,250 | D | ↗ |
| 2025-02-05 | MOORE ALISON | Officer | A-Award | A | Stock Option (Right to Buy) | 161,250 | 4.37 | 704.7K | 161,250 | D | ↗ |
| 2025-02-05 | Erbez Georgia | Officer | A-Award | A | Stock Option (Right to Buy) | 161,250 | 4.37 | 704.7K | 161,250 | D | ↗ |
| 2025-02-05 | DILLY STEPHEN GEORGE | Director / Officer | A-Award | A | Common Stock | 88,750 | 0.00 | — | 673,053 | D | ↗ |
| 2025-01-31 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 45,000 | 4.29 | 193.2K | 8,655,000 | I | ↗ |
| 2025-01-30 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 20,000 | 4.49 | 89.8K | 8,610,000 | I | ↗ |
| 2025-01-14 | Richards Christos | Director | A-Award | A | Common Stock | 44,150 | 0.00 | — | 44,150 | D | ↗ |
| 2024-12-31 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 10,000 | 4.66 | 46.6K | 8,590,000 | I | ↗ |
| 2024-12-30 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 35,000 | 4.70 | 164.4K | 8,580,000 | I | ↗ |
| 2024-11-07 | De Vre Raymond | Director | A-Award | A | Common Stock | 47,846 | 0.00 | — | 47,846 | D | ↗ |
| 2024-10-25 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 25,000 | 2.91 | 72.7K | 8,545,000 | I | ↗ |
| 2024-10-10 | MOORE ALISON | Officer | A-Award | A | Stock Option (Right to Buy) | 300,000 | 2.97 | 891.0K | 300,000 | D | ↗ |
| 2024-10-10 | Erbez Georgia | Officer | A-Award | A | Stock Option (Right to Buy) | 300,000 | 2.97 | 891.0K | 300,000 | D | ↗ |
| 2024-09-30 | Erbez Georgia | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-09-25 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 5,000 | 2.86 | 14.3K | 8,520,000 | I | ↗ |
| 2024-09-24 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 80,000 | 2.94 | 234.9K | 8,515,000 | I | ↗ |
| 2024-09-23 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 45,000 | 2.94 | 132.5K | 8,435,000 | I | ↗ |
| 2024-09-20 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 1,010,000 | 3.01 | 3.04M | 8,390,000 | I | ↗ |
| 2024-09-18 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 55,000 | 3.16 | 174.0K | 7,380,000 | — | ↗ |
| 2024-06-11 | WOLF DENNIS P | Director | A-Award | A | Common Stock | 30,120 | 0.00 | — | 106,920 | — | ↗ |
| 2024-06-11 | Smith David V | Director | A-Award | A | Common Stock | 30,120 | 0.00 | — | 64,722 | — | ↗ |
| 2024-06-11 | Singhvi Rahul | Director | A-Award | A | Common Stock | 30,120 | 0.00 | — | 96,069 | — | ↗ |
| 2024-06-11 | PARKER H STEWART | Director | A-Award | A | Common Stock | 30,120 | 0.00 | — | 102,600 | — | ↗ |
| 2024-06-11 | Martinborough Esther | Director | A-Award | A | Common Stock | 30,120 | 0.00 | — | 88,053 | — | ↗ |
| 2024-06-11 | MOORE ALISON | Director | A-Award | A | Common Stock | 30,120 | 0.00 | — | 98,696 | — | ↗ |
| 2024-06-11 | Dorgan Byron L | Director | A-Award | A | Common Stock | 30,120 | 0.00 | — | 223,581 | — | ↗ |
| 2024-01-01 | Ryali Sriram | Officer | A-Award | A | Stock Option (Right to Buy) | 314,125 | 3.05 | 958.1K | 314,125 | — | ↗ |
| 2024-01-01 | Norrett Kevin | Officer | A-Award | A | Stock Option (Right to Buy) | 314,125 | 3.05 | 958.1K | 314,125 | — | ↗ |
| 2024-01-01 | Fitzgerald Margaret Nell | Officer | A-Award | A | Stock Option (Right to Buy) | 314,125 | 3.05 | 958.1K | 314,125 | — | ↗ |
| 2024-01-01 | DILLY STEPHEN GEORGE | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 860,500 | 3.05 | 2.62M | 860,500 | — | ↗ |
| 2023-11-15 | Dorgan Byron L | Director | S-Sale | D | Common Stock | 20,000 | 2.11 | 42.2K | 193,461 | — | ↗ |
| 2023-11-09 | Singhvi Rahul | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 1.60 | 16.0K | 10,000 | — | ↗ |
| 2023-09-11 | Norrett Kevin | Officer | P-Purchase | A | Common Stock | 9,000 | 1.72 | 15.5K | 98,102 | — | ↗ |
| 2023-09-08 | Ryali Sriram | Officer | P-Purchase | A | Common Stock | 11,650 | 1.70 | 19.9K | 123,441 | — | ↗ |
| 2023-09-08 | Fitzgerald Margaret Nell | Officer | P-Purchase | A | Common Stock | 11,834 | 1.70 | 20.1K | 81,420 | — | ↗ |
| 2023-09-08 | DILLY STEPHEN GEORGE | Director / Officer | P-Purchase | A | Common Stock | 58,479 | 1.73 | 101.0K | 438,878 | — | ↗ |
| 2023-06-13 | WOLF DENNIS P | Director | A-Award | A | Common Stock | 34,602 | 0.00 | — | 76,800 | — | ↗ |
| 2023-06-13 | Smith David V | Director | A-Award | A | Common Stock | 34,602 | 0.00 | — | 34,602 | — | ↗ |
| 2023-06-13 | Singhvi Rahul | Director | A-Award | A | Common Stock | 34,602 | 0.00 | — | 65,949 | — | ↗ |
| 2023-06-13 | PARKER H STEWART | Director | A-Award | A | Common Stock | 34,602 | 0.00 | — | 72,480 | — | ↗ |
| 2023-06-13 | Martinborough Esther | Director | A-Award | A | Common Stock | 34,602 | 0.00 | — | 57,933 | — | ↗ |
| 2023-06-13 | MOORE ALISON | Director | A-Award | A | Common Stock | 34,602 | 0.00 | — | 68,576 | — | ↗ |
| 2023-06-13 | Dorgan Byron L | Director | A-Award | A | Common Stock | 34,602 | 0.00 | — | 213,461 | — | ↗ |
| 2023-06-13 | Aaker Jennifer | Director | A-Award | A | Common Stock | 34,602 | 0.00 | — | 66,211 | — | ↗ |
| 2023-04-18 | NICOLS JOHN J | Director | M-Exempt | D | Stock Option (Right to Buy) | 35,714 | 1.97 | 70.4K | 142,856 | — | ↗ |
| 2023-04-17 | NICOLS JOHN J | Director | M-Exempt | D | Stock Option (Right to Buy) | 35,714 | 1.97 | 70.4K | 178,570 | — | ↗ |
| 2023-03-16 | NICOLS JOHN J | Director | M-Exempt | A | Common Stock | 35,714 | 1.97 | 70.4K | 819,679 | — | ↗ |
| 2023-03-15 | NICOLS JOHN J | Director | S-Sale | D | Common Stock | 35,714 | 4.09 | 146.1K | 783,965 | — | ↗ |
| 2023-03-08 | Norrett Kevin | Officer | S-Sale | D | Common Stock | 8,258 | 4.56 | 37.6K | 89,102 | — | ↗ |
| 2023-03-08 | Fitzgerald Margaret Nell | Officer | S-Sale | D | Common Stock | 7,686 | 4.56 | 35.0K | 69,586 | — | ↗ |
| 2023-03-08 | DILLY STEPHEN GEORGE | Director / Officer | S-Sale | D | Common Stock | 26,987 | 4.56 | 122.9K | 380,399 | — | ↗ |
| 2023-03-07 | Norrett Kevin | Officer | S-Sale | D | Common Stock | 8,596 | 4.60 | 39.6K | 97,360 | — | ↗ |
| 2023-03-07 | Fitzgerald Margaret Nell | Officer | S-Sale | D | Common Stock | 8,000 | 4.60 | 36.8K | 77,272 | — | ↗ |
| 2023-03-07 | DILLY STEPHEN GEORGE | Director / Officer | S-Sale | D | Common Stock | 28,088 | 4.60 | 129.3K | 407,386 | — | ↗ |
| 2023-02-24 | NICOLS JOHN J | Director | M-Exempt | A | Common Stock | 35,714 | 1.97 | 70.4K | 819,679 | — | ↗ |
| 2023-02-23 | NICOLS JOHN J | Director | S-Sale | D | Common Stock | 39,785 | 5.36 | 213.2K | 783,965 | — | ↗ |
| 2023-02-21 | Norrett Kevin | Officer | A-Award | A | Stock Option (Right to Buy) | 67,500 | 5.44 | 367.2K | 67,500 | — | ↗ |
| 2023-02-21 | Fitzgerald Margaret Nell | Officer | A-Award | A | Stock Option (Right to Buy) | 25,000 | 5.44 | 136.0K | 25,000 | — | ↗ |
| 2023-02-21 | DILLY STEPHEN GEORGE | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 337,500 | 5.44 | 1.84M | 337,500 | — | ↗ |
| 2023-02-10 | Ryali Sriram | Officer | A-Award | A | Common Stock | 111,791 | 0.00 | — | 111,791 | — | ↗ |
| 2023-02-08 | Norrett Kevin | Officer | A-Award | A | Common Stock | 83,456 | 0.00 | — | 105,956 | — | ↗ |
| 2023-02-08 | Fitzgerald Margaret Nell | Officer | A-Award | A | Common Stock | 77,272 | 0.00 | — | 85,272 | — | ↗ |
| 2023-02-08 | DILLY STEPHEN GEORGE | Director / Officer | A-Award | A | Common Stock | 289,000 | 0.00 | — | 435,474 | — | ↗ |
| 2023-02-07 | TAYLOR DEAN ROSS JR | — | F-InKind | D | Common Stock | 1,224 | 6.51 | 8.0K | 38,554 | — | ↗ |
| 2023-01-24 | NICOLS JOHN J | Director | M-Exempt | D | Stock Option (Right to Buy) | 35,714 | 0.00 | — | 321,426 | — | ↗ |
| 2023-01-23 | Ryali Sriram | — | — | — | — | — | — | — | 0 | — | ↗ |
| 2022-12-16 | PARKER H STEWART | Director | A-Award | A | Common Stock | 37,878 | 0.00 | — | 37,878 | — | ↗ |
| 2022-12-12 | NICOLS JOHN J | Director | M-Exempt | A | Common Stock | 35,714 | 1.97 | 70.4K | 899,249 | — | ↗ |
| 2022-11-16 | NICOLS JOHN J | Director | M-Exempt | A | Common Stock | 35,714 | 1.97 | 70.4K | 939,034 | — | ↗ |
| 2022-11-08 | Fitzgerald Margaret Nell | Officer | A-Award | A | Stock Option (Right to Buy) | 382,775 | 0.00 | — | 382,775 | — | ↗ |
| 2022-10-31 | Fitzgerald Margaret Nell | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-10-28 | NICOLS JOHN J | Director | M-Exempt | D | Stock Option (Right to Buy) | 35,716 | 0.00 | — | 428,568 | — | ↗ |
| 2022-10-06 | NICOLS JOHN J | Director | M-Exempt | A | Common Stock | 35,716 | 1.97 | 70.4K | 1,018,608 | — | ↗ |
| 2022-10-05 | NICOLS JOHN J | Director | S-Sale | D | Common Stock | 39,787 | 6.04 | 240.1K | 982,892 | — | ↗ |
| 2022-10-03 | Norrett Kevin | Officer | A-Award | A | Stock Option (Right to Buy) | 413,405 | 0.00 | — | 413,405 | — | ↗ |
| 2022-09-28 | Singhvi Rahul | Director | A-Award | A | Common Stock | 31,347 | 0.00 | — | 31,347 | — | ↗ |
| 2022-08-12 | NICOLS JOHN J | Director | S-Sale | D | Common Stock | 39,000 | 8.78 | 342.6K | 1,022,679 | — | ↗ |
| 2022-08-01 | DILLY STEPHEN GEORGE | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 700,000 | 6.73 | 4.71M | 700,000 | — | ↗ |
| 2022-06-14 | Yang Patrick Y | Director | A-Award | A | Common Stock | 11,273 | 0.00 | — | 53,785 | — | ↗ |
| 2022-06-14 | WOLF DENNIS P | Director | A-Award | A | Common Stock | 11,273 | 0.00 | — | 42,198 | — | ↗ |
| 2022-06-14 | Smith David V | Director | G-Gift | D | Common Stock | 4,796 | 0.00 | — | 0 | — | ↗ |
| 2022-06-14 | Martinborough Esther | Director | A-Award | A | Common Stock | 11,273 | 0.00 | — | 23,331 | — | ↗ |
| 2022-06-14 | MOORE ALISON | Director | A-Award | A | Common Stock | 11,273 | 0.00 | — | 33,974 | — | ↗ |
| 2022-06-14 | Dorgan Byron L | Director | A-Award | A | Common Stock | 11,273 | 0.00 | — | 178,859 | — | ↗ |
| 2022-06-14 | DILLY STEPHEN GEORGE | Director | A-Award | A | Common Stock | 11,273 | 0.00 | — | 33,974 | — | ↗ |
| 2022-06-14 | Aaker Jennifer | Director | A-Award | A | Common Stock | 11,273 | 0.00 | — | 31,609 | — | ↗ |
| 2022-05-26 | Dorgan Byron L | Director | M-Exempt | A | Common Stock | 20,000 | 3.62 | 72.4K | 167,586 | — | ↗ |
| 2022-05-11 | NICOLS JOHN J | Officer | S-Sale | D | Common Stock | 16,409 | 10.61 | 174.2K | 1,022,679 | — | ↗ |
| 2022-03-23 | WOLF DENNIS P | Director | S-Sale | D | Common Stock | 4,000 | 20.49 | 81.9K | 30,925 | — | ↗ |
| 2022-03-15 | Yang Patrick Y | Director | S-Sale | D | Common Stock | 8,000 | 16.79 | 134.3K | 42,512 | — | ↗ |
| 2022-03-09 | NICOLS JOHN J | Officer | S-Sale | D | Common Stock | 38,500 | 18.93 | 728.7K | 1,022,679 | — | ↗ |
| 2022-03-05 | TAYLOR DEAN ROSS JR | Officer | F-InKind | D | Common Stock | 2,414 | 19.30 | 46.6K | 39,778 | — | ↗ |
| 2022-02-08 | TAYLOR DEAN ROSS JR | Officer | A-Award | A | Common Stock | 11,640 | 0.00 | — | 35,205 | — | ↗ |
| 2022-02-08 | NICOLS JOHN J | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 200,062 | 26.16 | 5.23M | 200,062 | — | ↗ |
| 2022-02-07 | TAYLOR DEAN ROSS JR | Officer | A-Award | A | Common Stock | 9,000 | 0.00 | — | 44,205 | — | ↗ |
| 2022-02-07 | NICOLS JOHN J | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 40,000 | 19.39 | 775.6K | 40,000 | — | ↗ |
| 2021-12-20 | WOLF DENNIS P | Director | S-Sale | D | Common Stock | 2,596 | 28.43 | 73.8K | 37,329 | — | ↗ |
| 2021-12-13 | Yang Patrick Y | Director | S-Sale | D | Common Stock | 7,800 | 31.59 | 246.4K | 50,712 | — | ↗ |
| 2021-11-11 | NICOLS JOHN J | Director / Officer | S-Sale | D | Common Stock | 11,327 | 39.07 | 442.6K | 1,022,679 | — | ↗ |
| 2021-11-10 | NICOLS JOHN J | Director / Officer | M-Exempt | A | Common Stock | 35,000 | 3.46 | 121.1K | 1,057,679 | — | ↗ |
| 2021-10-18 | Dorgan Byron L | Director | S-Sale | D | Common Stock | 17,400 | 27.86 | 484.7K | 150,186 | — | ↗ |
| 2021-10-15 | WOLF DENNIS P | Director | S-Sale | D | Common Stock | 5,900 | 28.30 | 166.9K | 40,025 | — | ↗ |
| 2021-09-15 | Smith David V | Director | — | D | Common Stock | 0 | 0.00 | — | 4,796 | — | ↗ |
| 2021-08-13 | NICOLS JOHN J | Director / Officer | M-Exempt | A | Common Stock | 35,000 | 3.46 | 121.1K | 1,057,679 | — | ↗ |
| 2021-08-12 | NICOLS JOHN J | Director / Officer | S-Sale | D | Common Stock | 34,066 | 24.51 | 834.9K | 1,023,613 | — | ↗ |
| 2021-08-10 | KELLEY BERNARD J | Director | M-Exempt | D | Stock Option (Right to Buy) | 20,000 | 3.62 | 72.4K | 0 | — | ↗ |
| 2021-06-16 | Yang Patrick Y | Director | S-Sale | D | Common Stock | 20,000 | 20.31 | 406.2K | 58,512 | — | ↗ |
| 2021-06-15 | Yang Patrick Y | Director | A-Award | A | Common Stock | 4,796 | 0.00 | — | 78,512 | — | ↗ |
| 2021-06-15 | WOLF DENNIS P | Director | A-Award | A | Common Stock | 4,796 | 0.00 | — | 45,925 | — | ↗ |
| 2021-06-15 | Smith David V | Director | A-Award | A | Common Stock | 4,796 | 0.00 | — | 4,796 | — | ↗ |
| 2021-06-15 | Martinborough Esther | Director | A-Award | A | Common Stock | 4,796 | 0.00 | — | 12,058 | — | ↗ |
| 2021-06-15 | MOORE ALISON | Director | A-Award | A | Common Stock | 4,796 | 0.00 | — | 22,701 | — | ↗ |
| 2021-06-15 | Dorgan Byron L | Director | A-Award | A | Common Stock | 4,796 | 0.00 | — | 167,586 | — | ↗ |
| 2021-06-15 | DILLY STEPHEN GEORGE | Director | A-Award | A | Common Stock | 4,796 | 0.00 | — | 22,701 | — | ↗ |
| 2021-06-15 | Aaker Jennifer | Director | A-Award | A | Common Stock | 4,796 | 0.00 | — | 20,336 | — | ↗ |
| 2021-05-18 | NICOLS JOHN J | Director / Officer | S-Sale | D | Common Stock | 13,877 | 18.56 | 257.6K | 1,043,802 | — | ↗ |
| 2021-05-17 | NICOLS JOHN J | Director / Officer | S-Sale | D | Common Stock | 35,385 | 18.12 | 641.3K | 1,022,679 | — | ↗ |
| 2021-04-21 | KELLEY BERNARD J | Director | S-Sale | D | Common Stock | 2,500 | 22.64 | 56.6K | 206,136 | — | ↗ |
| 2021-04-06 | Yang Patrick Y | Director | S-Sale | A | Common Stock | 10,000 | 25.15 | 251.5K | 73,716 | — | ↗ |
| 2021-04-05 | Yang Patrick Y | Director | S-Sale | D | Common Stock | 10,000 | 24.27 | 242.7K | 83,716 | — | ↗ |
| 2021-03-25 | WOLF DENNIS P | Director | S-Sale | D | Common Stock | 5,142 | 20.07 | 103.2K | 45,987 | — | ↗ |
| 2021-03-08 | KELLEY BERNARD J | Director | M-Exempt | D | Stock Option (Right to Buy) | 20,000 | 10.51 | 210.2K | 0 | — | ↗ |
| 2021-03-05 | TAYLOR DEAN ROSS JR | Officer | F-InKind | D | Common Stock | 2,419 | 19.51 | 47.2K | 23,565 | — | ↗ |
| 2021-02-16 | TAYLOR DEAN ROSS JR | Officer | A-Award | A | Common Stock | 5,000 | 0.00 | — | 25,984 | — | ↗ |
| 2021-02-16 | NICOLS JOHN J | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 198,000 | 14.43 | 2.86M | 198,000 | — | ↗ |
| 2021-02-11 | TAYLOR DEAN ROSS JR | Officer | F-InKind | D | Common Stock | 1,096 | 26.67 | 29.2K | 6,904 | — | ↗ |
| 2021-02-02 | Martinborough Esther | Director | A-Award | A | Common Stock | 7,262 | 0.00 | — | 7,262 | — | ↗ |
| 2021-01-21 | KELLEY BERNARD J | Director | S-Sale | D | Common Stock | 2,500 | 24.98 | 62.4K | 208,636 | — | ↗ |
| 2021-01-21 | Dorgan Byron L | Director | S-Sale | D | Common Stock | 25,000 | 25.17 | 629.2K | 162,790 | — | ↗ |
| 2021-01-20 | Dorgan Byron L | Director | M-Exempt | D | Stock Option (Right to Buy) | 25,000 | 10.63 | 265.8K | 25,000 | — | ↗ |
| 2020-12-21 | WOLF DENNIS P | Director | S-Sale | D | Common Stock | 10,000 | 19.99 | 199.9K | 51,129 | — | ↗ |
| 2020-10-21 | KELLEY BERNARD J | Director | S-Sale | D | Common Stock | 2,500 | 14.00 | 35.0K | 211,136 | — | ↗ |
| 2020-10-09 | Dorgan Byron L | Director | M-Exempt | D | Stock Option (Right to Buy) | 25,000 | 10.63 | 265.8K | 50,000 | — | ↗ |
| 2020-10-08 | Dorgan Byron L | Director | S-Sale | D | Common Stock | 25,000 | 13.49 | 337.3K | 162,790 | — | ↗ |
| 2020-09-24 | WOLF DENNIS P | Director | S-Sale | D | Common Stock | 10,000 | 11.68 | 116.8K | 61,129 | — | ↗ |
| 2020-08-05 | Aaker Jennifer | Director | A-Award | A | Common Stock | 15,540 | 0.00 | — | 15,540 | — | ↗ |
| 2020-07-21 | KELLEY BERNARD J | Director | S-Sale | D | Common Stock | 2,500 | 12.79 | 32.0K | 213,636 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-203.9K
Shares Outstanding
90.87M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Alison Moore, Ph.D. President and Chief Executive Officer | 524.7K | — | 256.0K | 1.07M | 463.1K | 14.2K | 2.32M | 56.87% | ↗ |
| 2 | 2025 | Stephen G. Dilly, M.B.B.S., Ph.D. Executive Chair of the Board of Directors and former President and Chief Executive Officer | 758.9K | — | 375.0K | 489.7K | 521.1K | 50.0K | 2.19M | 39.40% | ↗ |
| 3 | 2025 | Georgia Erbez Chief Financial Officer and Chief Business Officer | 507.4K | — | 117.4K | 487.5K | 237.5K | 1.0K | 1.35M | 44.78% | ↗ |
| 4 | 2025 | Kevin Norrett, M.B.A. Former Chief Operating Officer | 501.3K | — | 57.3K | 10.6K | 250.0K | 514.7K | 1.33M | 5.09% | ↗ |
| 5 | 2025 | Stefan Lutz, Ph.D. Chief Scientific Officer | 481.6K | — | 76.5K | 317.5K | 232.8K | 14.8K | 1.12M | 35.08% | ↗ |
| 6 | 2024 | Stephen Dilly, M.B.B.S., Ph.D. Chairman of the Board of Directors, President, and Chief Executive Officer | 713.6K | — | 437.4K | 1.73M | 535.2K | 53.8K | 3.47M | 62.50% | ↗ |
| 7 | 2024 | Stephen G. Dilly, M.B.B.S., Ph.D. Executive Chair of the Board of Directors and former President and Chief Executive Officer | 713.6K | — | 437.4K | 1.73M | 535.2K | 53.8K | 3.47M | 62.50% | ↗ |
| 8 | 2024 | Kevin Norrett, M.B.A. Chief Operating Officer | 474.5K | — | 159.7K | 632.6K | 237.2K | 14.8K | 1.52M | 52.16% | ↗ |
| 9 | 2024 | Kevin Norrett, M.B.A. Former Chief Operating Officer | 474.5K | — | 159.7K | 632.6K | 237.2K | 14.8K | 1.52M | 52.16% | ↗ |
| 10 | 2024 | Margaret Nell Fitzgerald Former Chief Legal and Compliance Officer, General Counsel and Secretary | 350.3K | — | 159.7K | 632.6K | 171.9K | 185.5K | 1.50M | 52.82% | ↗ |
| 11 | 2024 | Sriram Ryali, M.B.A. Former Chief Financial Officer | 354.2K | — | 159.7K | 632.6K | 173.8K | 163.4K | 1.48M | 53.40% | ↗ |
| 12 | 2024 | Alison Moore, Ph.D. President and Chief Executive Officer | 115.4K | — | 248.5K | 609.8K | 57.7K | 71.6K | 1.10M | 77.82% | ↗ |
| 13 | 2024 | Alison Moore, Ph.D. Executive Vice President and Chief Technical Officer | 115.4K | — | 248.5K | 609.8K | 57.7K | 71.6K | 1.10M | 77.82% | ↗ |
| 14 | 2024 | Georgia Erbez Chief Financial Officer | 115.4K | — | 148.5K | 609.8K | 57.7K | 240.00 | 931.6K | 81.40% | ↗ |
| 15 | 2024 | Georgia Erbez Chief Financial Officer and Chief Business Officer | 115.4K | — | 148.5K | 609.8K | 57.7K | 240.00 | 931.6K | 81.40% | ↗ |
| 16 | 2023 | Stephen Dilly, M.B.B.S, Ph.D. President and Chief Executive Officer | 710.0K | — | 612.0K | 1.14M | 585.8K | 69.9K | 3.12M | 56.26% | ↗ |
| 17 | 2023 | Stephen Dilly, M.B.B.S., Ph.D. Chairman of the Board of Directors, President, and Chief Executive Officer | 710.0K | — | 612.0K | 1.14M | 585.8K | 69.9K | 3.12M | 56.26% | ↗ |
| 18 | 2023 | Sriram Ryali, M.B.A. Former Chief Financial Officer | 423.4K | 100.0K | 655.1K | 1.35M | 232.9K | 14.1K | 2.78M | 72.29% | ↗ |
| 19 | 2023 | Sriram Ryali, M.B.A. Chief Financial Officer | 423.4K | 100.0K | 655.1K | 1.35M | 232.9K | 14.1K | 2.78M | 72.29% | ↗ |
| 20 | 2023 | Kevin Norrett, M.B.A. Chief Operating Officer | 468.0K | — | 122.4K | 228.9K | 257.4K | 14.2K | 1.09M | 32.21% | ↗ |
| 21 | 2023 | Margaret Nell Fitzgerald Former Chief Legal and Compliance Officer, General Counsel and Secretary | 445.0K | — | 43.5K | 84.8K | 244.8K | 14.2K | 832.2K | 15.42% | ↗ |
| 22 | 2022 | Stephen Dilly, M.B.B.S, Ph.D. President and Chief Executive Officer | 279.4K | 200.0K | 2.39M | 2.75M | 190.1K | 84.1K | 5.89M | 87.21% | ↗ |
| 23 | 2022 | Stephen Dilly, M.B.B.S., Ph.D. Chairman of the Board of Directors, President, and Chief Executive Officer | 279.4K | 200.0K | 2.39M | 2.75M | 190.1K | 84.1K | 5.89M | 87.21% | ↗ |
| 24 | 2022 | John J. Nicols Former President and Chief Executive Officer | 603.2K | — | — | 2.52M | 282.5K | 13.0K | 3.42M | 73.72% | ↗ |
| 25 | 2022 | Kevin Norrett, M.B.A. Chief Operating Officer | 112.5K | — | 596.0K | 1.52M | 47.8K | 240.00 | 2.28M | 92.95% | ↗ |
| 26 | 2022 | Kevin Norrett Chief Operating Officer | 112.5K | — | 596.0K | 1.52M | 47.8K | 240.00 | 2.28M | 92.95% | ↗ |
| 27 | 2022 | Margaret Nell Fitzgerald Chief Legal and Compliance Officer, General Counsel and Secretary | 74.2K | 200.0K | 466.0K | 1.41M | 25.7K | 160.00 | 2.18M | 86.24% | ↗ |
| 28 | 2022 | Margaret Nell Fitzgerald Former Chief Legal and Compliance Officer, General Counsel and Secretary | 74.2K | 200.0K | 466.0K | 1.41M | 25.7K | 160.00 | 2.18M | 86.24% | ↗ |
| 29 | 2022 | Ross Taylor Senior Vice President, Chief Financial Officer | 426.4K | — | 368.4K | 326.3K | 185.7K | 13.6K | 1.32M | 52.61% | ↗ |
| 30 | 2021 | John J. Nicols President and Chief Executive Officer | 696.6K | — | — | 2.11M | 619.0K | 13.0K | 3.44M | 61.36% | ↗ |
| 31 | 2021 | John J. Nicols Former President and Chief Executive Officer | 696.6K | — | — | 2.11M | 619.0K | 13.0K | 3.44M | 61.36% | ↗ |
| 32 | 2021 | Ross Taylor Senior Vice President, Chief Financial Officer | 408.3K | — | 340.1K | 256.8K | 246.0K | 13.0K | 1.26M | 47.21% | ↗ |
| 33 | 2020 | John J. Nicols President and Chief Executive Officer | 686.7K | 168.2K | — | 1.80M | 297.6K | 12.6K | 2.96M | 60.65% | ↗ |
| 34 | 2020 | John J. Nicols Former President and Chief Executive Officer | 686.7K | 168.2K | — | 1.80M | 297.6K | 12.6K | 2.96M | 60.65% | ↗ |
| 35 | 2020 | Ross Taylor Senior Vice President, Chief Financial Officer | 406.9K | 67.0K | — | 228.6K | 118.5K | 12.6K | 833.5K | 27.42% | ↗ |
| 36 | 2019 | John J. Nicols President and Chief Executive Officer | 628.0K | — | — | 2.35M | 422.0K | 12.6K | 3.41M | 68.82% | ↗ |
| 37 | 2019 | Gordon Sangster Former Senior Vice President, Chief Financial Officer | 254.3K | — | — | 800.9K | — | 12.3K | 1.07M | 75.03% | ↗ |
| 38 | 2019 | James J. Lalonde, Former Senior Vice President, Research and Development | 120.5K | — | — | 726.5K | — | 6.7K | 853.8K | 85.10% | ↗ |
| 39 | 2019 | Ross Taylor Senior Vice President, Chief Financial Officer | 148.9K | — | — | 264.2K | 62.0K | 4.5K | 479.6K | 55.10% | ↗ |
| 40 | 2018 | John J. Nicols President and Chief Executive Officer | 646.8K | — | — | 2.29M | 494.5K | 12.0K | 3.44M | 66.46% | ↗ |
| 41 | 2018 | Gordon Sangster Senior Vice President, Chief Financial Officer | 403.0K | — | — | 778.5K | 205.4K | 12.0K | 1.40M | 55.65% | ↗ |
| 42 | 2018 | Gordon Sangster Former Senior Vice President, Chief Financial Officer | 403.0K | — | — | 778.5K | 205.4K | 12.0K | 1.40M | 55.65% | ↗ |
| 43 | 2018 | Michael Aldridge Senior Vice President, Corporate and Strategic Development | 283.3K | — | — | 778.5K | — | 234.1K | 1.30M | 60.07% | ↗ |
| 44 | 2018 | James J. Lalonde, Former Senior Vice President, Research and Development | 356.0K | — | — | 703.2K | 181.5K | 12.0K | 1.25M | 56.13% | ↗ |
| 45 | 2018 | James J. Lalonde, Senior Vice President, Research and Development | 356.0K | — | — | 703.2K | 181.5K | 12.0K | 1.25M | 56.13% | ↗ |
| 46 | 2017 | John J. Nicols President and Chief Executive Officer | 627.5K | — | — | 1.83M | 473.0K | 12.0K | 2.94M | 62.19% | ↗ |
| 47 | 2017 | Gordon Sangster Former Senior Vice President, Chief Financial Officer | 390.8K | — | — | 635.4K | 196.0K | 12.0K | 1.23M | 51.48% | ↗ |
| 48 | 2017 | Michael Aldridge Senior Vice President, Corporate and Strategic Development | 390.8K | — | — | 635.4K | 196.0K | 12.0K | 1.23M | 51.48% | ↗ |
| 49 | 2017 | Gordon Sangster Senior Vice President, Chief Financial Officer | 390.8K | — | — | 635.4K | 196.0K | 12.0K | 1.23M | 51.48% | ↗ |
| 50 | 2017 | James J. Lalonde, Former Senior Vice President, Research and Development | 329.2K | — | — | 559.1K | 165.0K | 12.0K | 1.07M | 52.48% | ↗ |
| 51 | 2017 | James J. Lalonde, Senior Vice President, Research and Development | 329.2K | — | — | 559.1K | 165.0K | 12.0K | 1.07M | 52.48% | ↗ |
| 52 | 2016 | John J. Nicols President and Chief Executive Officer | 610.0K | — | 1.21M | 486.7K | 494.0K | 12.0K | 2.82M | 60.37% | ↗ |
| 53 | 2016 | Gordon Sangster Senior Vice President, Chief Financial Officer | 374.2K | — | 303.4K | 283.7K | 205.0K | 12.0K | 1.18M | 49.83% | ↗ |
| 54 | 2016 | James J. Lalonde, Senior Vice President, Research and Development | 312.5K | — | 192.7K | 177.6K | 156.0K | 12.0K | 850.9K | 43.52% | ↗ |
| 55 | 2016 | Michael Aldridge Senior Vice President, Corporate and Strategic Development | 79.2K | — | — | 593.2K | 43.0K | 2.8K | 718.2K | 82.59% | ↗ |
| 56 | 2016 | Douglas T. Sheehy Executive Vice President, Chief Administrative Officer, General Counsel and Secretary | 158.6K | — | 303.4K | 283.7K | — | 4.9K | 163.5K | 359.21% | ↗ |
| 57 | 2015 | John J. Nicols President and Chief Executive Officer | 610.0K | — | 949.2K | 628.0K | 439.0K | 12.0K | 2.64M | 59.78% | ↗ |
| 58 | 2015 | Douglas T. Sheehy Executive Vice President, Chief Administrative Officer, General Counsel and Secretary | 405.0K | — | 291.5K | 287.3K | 194.0K | 12.0K | 1.19M | 48.65% | ↗ |
| 59 | 2015 | Gordon Sangster Senior Vice President, Chief Financial Officer | 345.0K | — | 278.0K | 273.0K | 179.0K | 12.0K | 1.09M | 50.69% | ↗ |
| 60 | 2015 | Gordon Sangster Senior Vice President and Chief Financial Officer | 345.0K | — | 278.0K | 273.0K | 179.0K | 12.0K | 1.09M | 50.69% | ↗ |
| 61 | 2015 | James J. Lalonde, Senior Vice President, Research and Development | 275.0K | — | 145.8K | 143.7K | 116.0K | 12.0K | 692.5K | 41.80% | ↗ |
| 62 | 2014 | John J. Nicols President and Chief Executive Officer | 592.0K | — | 788.0K | 582.1K | 404.0K | 10.6K | 2.38M | 57.65% | ↗ |
| 63 | 2014 | John J. Nicols President and Chief Executive Officer | 592.0K | — | 788.0K | 582.1K | 404.0K | 10.6K | 2.38M | 57.65% | ↗ |
| 64 | 2014 | Douglas T. Sheehy Executive Vice President, Chief Administrative Officer, General Counsel and Secretary | 385.4K | — | 157.6K | 163.0K | 178.0K | 11.6K | 895.6K | 35.79% | ↗ |
| 65 | 2014 | Douglas T. Sheehy Executive Vice President, Chief Administrative Officer, General Counsel and Secretary | 385.4K | — | 157.6K | 163.0K | 178.0K | 11.6K | 895.6K | 35.79% | ↗ |
| 66 | 2014 | Gordon Sangster Senior Vice President, Chief Financial Officer | 121.9K | 50.0K | 245.0K | 174.1K | 44.0K | 5.5K | 640.5K | 65.44% | ↗ |
| 67 | 2014 | Gordon Sangster Senior Vice President and Chief Financial Officer | 121.9K | 50.0K | 245.0K | 174.1K | 44.0K | 5.5K | 640.5K | 65.44% | ↗ |
| 68 | 2014 | James J. Lalonde, Senior Vice President, Research and Development | 257.4K | — | 88.7K | 87.3K | 83.0K | 11.6K | 528.0K | 33.32% | ↗ |
| 69 | 2014 | James J. Lalonde, Senior Vice President, Research and Development | 257.4K | — | 88.7K | 87.3K | 83.0K | 11.6K | 528.0K | 33.32% | ↗ |
| 70 | 2014 | David McCaman | 204.0K | — | 107.5K | 46.6K | — | 1.3K | 359.4K | 42.87% | ↗ |
| 71 | 2014 | David D. O’Toole Former Senior Vice President and Chief Financial Officer | 171.2K | — | — | — | — | 780.00 | 172.0K | 0.00% | ↗ |
| 72 | 2013 | John J. Nicols President and Chief Executive Officer | 592.0K | 62.5K | 556.8K | 367.2K | 387.0K | 842.00 | 1.97M | 46.99% | ↗ |
| 73 | 2013 | John J. Nicols President and Chief Executive Officer | 592.0K | 62.5K | 556.8K | 367.2K | 387.0K | 842.00 | 1.97M | 46.99% | ↗ |
| 74 | 2013 | Douglas T. Sheehy Senior Vice President, General Counsel and Secretary | 334.8K | — | 415.0K | 103.4K | 146.0K | — | 999.1K | 51.88% | ↗ |
| 75 | 2013 | Douglas T. Sheehy Executive Vice President, Chief Administrative Officer, General Counsel and Secretary | 334.8K | — | 415.0K | 103.4K | 146.0K | — | 999.1K | 51.88% | ↗ |
| 76 | 2013 | Douglas T. Sheehy Executive Vice President, Chief Administrative Officer, General Counsel and Secretary | 334.8K | — | 415.0K | 103.4K | 146.0K | — | 999.1K | 51.88% | ↗ |
| 77 | 2013 | David D. O'Toole Senior Vice President and Chief Financial Officer | 334.8K | — | 210.6K | 103.4K | 82.0K | 10.7K | 741.4K | 42.35% | ↗ |
| 78 | 2013 | David D. O’Toole Former Senior Vice President and Chief Financial Officer | 334.8K | — | 207.4K | 103.4K | 82.0K | 10.7K | 738.2K | 42.10% | ↗ |
| 79 | 2013 | Matt Tobin Former Senior Vice President, Research and Development | 277.1K | — | 146.0K | 73.9K | — | 216.5K | 713.5K | 30.82% | ↗ |
| 80 | 2013 | David L. Anton Former Senior Vice President, BioIndustrials | 272.6K | — | 146.0K | 73.9K | — | 151.7K | 644.2K | 34.14% | ↗ |
| 81 | 2012 | John J. Nicols President and Chief Executive Officer | 323.1K | 62.5K | 2.60M | 801.7K | 128.2K | 92.3K | 4.00M | 84.86% | ↗ |
| 82 | 2012 | John J. Nicols President and Chief Executive Officer | 323.1K | 62.5K | 2.60M | 801.7K | 128.2K | 92.3K | 4.00M | 84.86% | ↗ |
| 83 | 2012 | Alan Shaw Former President and Chief Executive Officer | 68.8K | — | — | 225.7K | — | 787.8K | 1.02M | 22.12% | ↗ |
| 84 | 2012 | Peter Strumph Former Interim President and Chief Executive Officer | 216.1K | — | 143.9K | 113.7K | — | 295.5K | 769.2K | 33.49% | ↗ |
| 85 | 2012 | David D. O'Toole Senior Vice President and Chief Financial Officer | 106.0K | 50.0K | 136.0K | 319.3K | 22.7K | 27.4K | 661.4K | 68.84% | ↗ |
| 86 | 2012 | David D. O’Toole Former Senior Vice President and Chief Financial Officer | 106.0K | 50.0K | 130.0K | 319.3K | 22.7K | 27.4K | 655.3K | 68.55% | ↗ |
| 87 | 2012 | Douglas T. Sheehy Senior Vice President, General Counsel and Secretary | 325.0K | — | 113.9K | 113.7K | 76.2K | — | 628.8K | 36.20% | ↗ |
| 88 | 2012 | Douglas T. Sheehy Executive Vice President, Chief Administrative Officer, General Counsel and Secretary | 325.0K | — | 113.9K | 113.7K | 76.2K | — | 628.8K | 36.20% | ↗ |
| 89 | 2012 | David L. Anton Former Senior Vice President, BioIndustrials | 325.0K | — | 113.9K | 113.7K | 55.4K | — | 608.1K | 37.43% | ↗ |
| 90 | 2012 | David L. Anton Senior Vice President, BioIndustrials | 325.0K | — | 113.9K | 113.7K | 55.4K | — | 608.1K | 37.43% | ↗ |
| 91 | 2012 | Matt Tobin Former Senior Vice President, Research and Development | 253.7K | — | 53.4K | 55.9K | 55.7K | — | 418.7K | 26.10% | ↗ |
| 92 | 2012 | Matt Tobin Senior Vice President, Research and Development | 253.7K | — | 53.4K | 55.9K | 55.7K | — | 418.7K | 26.10% | ↗ |
| 93 | 2012 | Brian Dowd Former Interim Chief Financial Officer | 142.1K | — | 53.4K | 56.0K | — | — | 251.1K | 43.55% | ↗ |
| 94 | 2012 | Mark Ho Former Interim Controller | 166.0K | — | 36.4K | — | — | — | 202.4K | 17.99% | ↗ |
| 95 | 2012 | Robert J. Lawson Former Senior Vice President and Chief Financial Officer | 63.2K | — | — | — | — | — | 63.2K | 0.00% | ↗ |
| 96 | 2011 | Alan Shaw Former President and Chief Executive Officer | 490.0K | — | 686.3K | 638.5K | 220.5K | — | 2.04M | 65.09% | ↗ |
| 97 | 2011 | Robert J. Lawson Former Senior Vice President and Chief Financial Officer | 340.0K | — | 366.0K | 306.5K | 122.4K | — | 1.13M | 59.26% | ↗ |
| 98 | 2011 | David L. Anton Former Senior Vice President, BioIndustrials | 320.0K | — | 366.0K | 306.5K | 115.2K | — | 1.11M | 60.71% | ↗ |
| 99 | 2011 | David L. Anton Senior Vice President, BioIndustrials | 320.0K | — | 366.0K | 306.5K | 115.2K | — | 1.11M | 60.71% | ↗ |
| 100 | 2011 | Douglas T. Sheehy Senior Vice President, General Counsel and Secretary | 310.0K | — | 366.0K | 306.5K | 111.6K | — | 1.09M | 61.47% | ↗ |
| 101 | 2010 | Alan Shaw Former President and Chief Executive Officer | 460.0K | — | — | 1.97M | 396.8K | — | 2.83M | 69.71% | ↗ |
| 102 | 2010 | David L. Anton Senior Vice President, BioIndustrials | 290.0K | — | — | 394.4K | 186.8K | — | 871.2K | 45.27% | ↗ |
| 103 | 2010 | Robert J. Lawson Former Senior Vice President and Chief Financial Officer | 330.0K | — | — | 197.2K | 227.7K | — | 757.9K | 26.02% | ↗ |
| 104 | 2010 | Douglas T. Sheehy Senior Vice President, General Counsel and Secretary | 300.0K | — | — | 246.5K | 207.0K | — | 753.5K | 32.71% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Alison Moore | President, Chief Executive Officer & Director | 1M | — |
| Georgia L. Erbez | Chief Financial Officer & Chief Business Officer | 746.0K | female |
| Senator Byron L. Dorgan | Consultant | 103.6K | — |
| John Schiffhauer | Senior Vice President of Intellectual Property | — | male |
| Karen Frechou-Armijo | Senior Vice President & Head of Human Resources | — | female |
| Stefan Lutz | Chief Scientific Officer | — | — |
| Britton Jimenez | Senior Vice President of Sales & Marketing | — | male |
| Carrie McKim | Director of Investor Relations | — | female |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
| Transaction Date | Disclosed | Representative | District | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2018-04-06 | 2018-05-08 | Lamar Smith | TX21 | — | Purchase | $1,001 - $15,000 | ↗ |
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for CDXS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
